SOLAGRAN LIMITED
SLA - Upcoming General Meeting, Executive Reward Plan - Mr Denis Kilroy, Executive Director
Tuesday, 7 August 2007 11:00am
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Audio Duration: 21:11
Mr Denis Kilroy
Tue, 7 Aug 2007
11:00am Australia/Sydney
Select a tab above to display more information
SOLAGRAN LIMITED (SLA)
ASX code: SLA
Website: http://www.solagran.com
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Principal Activities:
Research and development of bio-medical products used in the treatment of cirrhosis, chronic hepatitis and other liver conditions.
Address:
, 480 St Kilda Road, Level 1,
MELBOURNE
VIC
Phone: (03) 9820 2699
Fax: (03) 9820 3155
Executives & Directors
Dr Vagif Soultanov , Executive Chairman
Mr Branko Jovanovic , CEO, Director
Mr Alexander Kurganov , Director
Mr Andi Solaiman , Non Exec. Director
Mr David Croll , CFO
Mr Justyn Stedwell , Company Secretary
Company Podcasts
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
SOLAGRAN LIMITED (SLA) Events
SOLAGRAN LIMITED (SLA)
| Change in substantial holding for BPO | Mon, 15 Mar 2010 |
| Market Update | Fri, 12 Mar 2010 |
| Russian Sales Update | Tue, 9 Mar 2010 |
| Half Yearly Report and Accounts | Fri, 26 Feb 2010 |
| BPO: BioProspect and Solagran agreement to commercialise | Thu, 25 Feb 2010 |
| Response to an ASX re 4C Query | Fri, 5 Feb 2010 |
| Russian Market Update | Fri, 5 Feb 2010 |
| Trading Halt | Wed, 3 Feb 2010 |
| Appendix 4C | Fri, 29 Jan 2010 |
| Appendix 3B | Mon, 21 Dec 2009 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.


















